BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20579816)

  • 1. Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors.
    Rades D; Freundt K; Meyners T; Bajrovic A; Basic H; Karstens JH; Adamietz IA; Wildfang I; Rudat V; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1492-7. PubMed ID: 20579816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
    Freundt K; Meyners T; Bajrovic A; Basic H; Karstens JH; Adamietz IA; Rudat V; Schild SE; Dunst J; Rades D
    Strahlenther Onkol; 2010 Apr; 186(4):218-23. PubMed ID: 20354660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors.
    Rades D; Huttenlocher S; Bajrovic A; Karstens JH; Adamietz IA; Kazic N; Rudat V; Schild SE
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e861-8. PubMed ID: 21277114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?
    Rades D; Dahm-Daphi J; Rudat V; Schulte R; Stalpers LJ; Veninga T; Hoskin PJ
    Strahlenther Onkol; 2006 Dec; 182(12):708-12. PubMed ID: 17149577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
    Rades D; Karstens JH; Hoskin PJ; Rudat V; Veninga T; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):525-31. PubMed ID: 17141977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study.
    Rades D; Walz J; Stalpers LJ; Veninga T; Schulte R; Obralic N; Wildfang I; Engenhart-Cabilic R; Hoskin PJ; Schild SE
    Eur Urol; 2006 May; 49(5):846-52; discussion 852. PubMed ID: 16442206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two different radiation schedules for metastatic spinal cord compression considering a new prognostic factor.
    Rades D; Karstens JH
    Strahlenther Onkol; 2002 Oct; 178(10):556-61. PubMed ID: 12386787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
    Rades D; Veninga T; Stalpers LJ; Schulte R; Hoskin PJ; Poortmans P; Schild SE; Rudat V
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):182-8. PubMed ID: 16198069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.
    Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Obralic N; Bajrovic A; Rudat V; Schwarz R; Hulshof MC; Poortmans P; Schild SE
    J Clin Oncol; 2005 May; 23(15):3366-75. PubMed ID: 15908648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
    Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy of metastatic spinal cord compression in very elderly patients.
    Rades D; Hoskin PJ; Karstens JH; Rudat V; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):256-63. PubMed ID: 17189074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.
    Rades D; Fehlauer F; Schulte R; Veninga T; Stalpers LJ; Basic H; Bajrovic A; Hoskin PJ; Tribius S; Wildfang I; Rudat V; Engenhart-Cabilic R; Karstens JH; Alberti W; Dunst J; Schild SE
    J Clin Oncol; 2006 Jul; 24(21):3388-93. PubMed ID: 16849752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression.
    Rades D; Lange M; Veninga T; Stalpers LJ; Bajrovic A; Adamietz IA; Rudat V; Schild SE
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):524-30. PubMed ID: 20452136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy.
    Sahgal A; Ma L; Weinberg V; Gibbs IC; Chao S; Chang UK; Werner-Wasik M; Angelov L; Chang EL; Sohn MJ; Soltys SG; Létourneau D; Ryu S; Gerszten PC; Fowler J; Wong CS; Larson DA
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):107-16. PubMed ID: 20951503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients.
    Rades D; Stalpers LJ; Schulte R; Veninga T; Basic H; Engenhart-Cabilic R; Schild SE; Hoskin PJ
    Eur J Cancer; 2006 May; 42(8):1052-6. PubMed ID: 16580192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and toxicity of single-fraction radiotherapy with 1 x 8 Gy for metastatic spinal cord compression.
    Rades D; Stalpers LJ; Hulshof MC; Zschenker O; Alberti W; Koning CC
    Radiother Oncol; 2005 Apr; 75(1):70-3. PubMed ID: 15878103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study.
    Rades D; Fehlauer F; Stalpers LJ; Wildfang I; Zschenker O; Schild SE; Schmoll HJ; Karstens JH; Alberti W
    Cancer; 2004 Dec; 101(11):2687-92. PubMed ID: 15493037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis.
    Rades D; Panzner A; Rudat V; Karstens JH; Schild SE
    Strahlenther Onkol; 2011 Nov; 187(11):729-35. PubMed ID: 22037654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
    Rades D; Rudat V; Veninga T; Stalpers LJ; Hoskin PJ; Schild SE
    Cancer; 2008 Sep; 113(5):1090-6. PubMed ID: 18642349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.
    Rades D; Hoskin PJ; Stalpers LJ; Schulte R; Poortmans P; Veninga T; Dahm-Daphi J; Obralic N; Wildfang I; Bahrehmand R; Engenhart-Cabilic R; Schild SE
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1452-7. PubMed ID: 16413695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.